Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)
1 other identifier
observational
505
1 country
1
Brief Summary
This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2024
CompletedFirst Submitted
Initial submission to the registry
April 29, 2024
CompletedFirst Posted
Study publicly available on registry
May 2, 2024
CompletedMay 2, 2024
April 1, 2024
3 years
April 29, 2024
April 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative recurrence rate
postoperative recurrence rate
2018-2024
Study Arms (2)
robotic surgery with cci
laparoscopic surgery with cci
Interventions
laparoscopic surgery
Eligibility Criteria
Participants who underwent robotic or laparoscopic anterior resection for rectal cancer.
You may qualify if:
- The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data.
You may not qualify if:
- patients with other malignant tumors besides rectal cancer, benign disease surgery, and emergency surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Daorong Wanglead
Study Sites (1)
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, 225001, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- DR
Study Record Dates
First Submitted
April 29, 2024
First Posted
May 2, 2024
Study Start
January 1, 2019
Primary Completion
January 1, 2022
Study Completion
January 3, 2024
Last Updated
May 2, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share